Analysts Set Veradigm Inc. (NASDAQ:MDRX) Price Target at $11.25

Shares of Veradigm Inc. (NASDAQ:MDRXGet Free Report) have been given an average rating of “Hold” by the five research firms that are currently covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $11.25.

Several equities analysts recently issued reports on the company. Royal Bank of Canada reduced their price target on Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a research report on Friday, January 19th. StockNews.com assumed coverage on Veradigm in a research report on Thursday. They set a “hold” rating for the company. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $10.00 target price (down previously from $15.00) on shares of Veradigm in a report on Tuesday, March 19th.

View Our Latest Stock Analysis on Veradigm

Veradigm Stock Up 1.8 %

Shares of MDRX opened at $7.75 on Tuesday. Veradigm has a 1-year low of $5.01 and a 1-year high of $14.09. The firm’s 50 day simple moving average is $7.73 and its 200 day simple moving average is $9.56.

Hedge Funds Weigh In On Veradigm

A number of hedge funds have recently bought and sold shares of MDRX. Robeco Institutional Asset Management B.V. grew its position in shares of Veradigm by 216.2% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 142,489 shares of the software maker’s stock valued at $1,872,000 after acquiring an additional 97,432 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Veradigm by 8.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 20,068 shares of the software maker’s stock valued at $264,000 after buying an additional 1,507 shares during the last quarter. Mackenzie Financial Corp boosted its position in shares of Veradigm by 34.1% during the third quarter. Mackenzie Financial Corp now owns 60,250 shares of the software maker’s stock worth $800,000 after acquiring an additional 15,318 shares during the last quarter. Assetmark Inc. grew its stake in Veradigm by 15.5% during the third quarter. Assetmark Inc. now owns 62,008 shares of the software maker’s stock valued at $815,000 after acquiring an additional 8,310 shares in the last quarter. Finally, Teacher Retirement System of Texas increased its holdings in Veradigm by 3.7% in the 3rd quarter. Teacher Retirement System of Texas now owns 73,490 shares of the software maker’s stock valued at $966,000 after acquiring an additional 2,639 shares during the last quarter.

Veradigm Company Profile

(Get Free Report

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

See Also

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.